Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein

Tumor necrosis factor α in the onset and progression of leukemia

(2017) Xiaoxi Zhou et al.   EXPERIMENTAL HEMATOLOGY

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells

(2017) Lan Deng et al.   Oncology Letters

Molecular targets of luteolin in cancer

(2016) Muobarak J. Tuorkey   EUROPEAN JOURNAL OF CANCER PREVENTION

How I treat refractory and early relapsed acute myeloid leukemia

(2015) F. Thol et al.   BLOOD

Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells

(2015) Pei-Yi Chen et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

(2015) Jacqueline E. Noll et al.   Journal of Hematology & Oncology

Small molecule Mcl-1 inhibitors for the treatment of cancer

(2015) Johannes Belmar et al.   PHARMACOLOGY & THERAPEUTICS

Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review

(2014) Ashok Kumar Pandurangan et al.   Asian Pacific Journal of Cancer Prevention

Prostate Cancer Cell Response to Paclitaxel Is Affected by Abnormally Expressed Securin PTTG1

(2014) C. Castilla et al.   MOLECULAR CANCER THERAPEUTICS

Flavonoids as receptor tyrosine kinase FLT3 inhibitors

(2013) Young-Won Chin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Acute myeloid leukemia associated with FGFR1 abnormalities

(2013) Hyeyoung Lee et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation

(2013) Pei-Yi Chen et al.   PLoS One

Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents

(2012) Edy Meiyanto et al.   Asian Pacific Journal of Cancer Prevention

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125

(2012) Simona Caporali et al.   BIOCHEMICAL PHARMACOLOGY

Role of p53 family members p73 and p63 in human hematological malignancies

(2012) Evguenia M. Alexandrova et al.   LEUKEMIA & LYMPHOMA

Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)

(2012) GUANHUA SONG et al.   ONCOLOGY REPORTS

Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells

(2012) Ho-Hsing Tseng et al.   PLoS One

Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells

(2012) Lian-Fang Lin et al.   PLoS One

Role of p63 in cancer development

(2011) Vincenzo Graziano et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Anti-carcinogenic Effects of the Flavonoid Luteolin

(2011) Günter Seelinger et al.   MOLECULES

Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling

(2011) Y C Liao et al.   ONCOGENE

Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway

(2010) Chye-Sun Ong et al.   CANCER LETTERS

Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells

(2010) Samir Attoub et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pituitary tumor-transforming gene and its binding factor in endocrine cancer

(2010) Vicki E. Smith et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Neurotrophic and Cytoprotective Action of Luteolin in PC12 Cells through ERK-Dependent Induction of Nrf2-Driven HO-1 Expression

(2010) Chia-Wei Lin et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3

(2010) M Wunderlich et al.   LEUKEMIA

Differentiation-associated alteration in sensitivity to apoptosis induced by (-)-epigallocatechin-3-O-gallate in HL-60 cells

(2009) Norihisa Okada et al.   BIOMEDICAL RESEARCH-TOKYO

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD

Transcriptional targets for pituitary tumor-transforming gene-1

(2009) Yunguang Tong et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Distribution and Biological Activities of the Flavonoid Luteolin

(2009) Miguel Lopez-Lazaro   MINI-REVIEWS IN MEDICINAL CHEMISTRY

New agents in acute myeloid leukemia: Beyond cytarabine and anthracyclines

(2009) Amir T. Fathi et al.   Current Oncology Reports

Chromosomal translocations: revisited yet again

(2008) J. D. Rowley   BLOOD

WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis

(2008) Y Li et al.   CELL DEATH AND DIFFERENTIATION

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

(2008) Yong Lin et al.   CURRENT CANCER DRUG TARGETS

Cell cycle control of pituitary development and disease

(2008) Victor Quereda et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY